(Q53221825)

12 May 2018

title

Fluoxetine for the treatment of fatigue in primary biliary cirrhosis: a randomized, double-blind controlled trial. (English)

1 reference

12 May 2018

primary biliary cholangitis

1 reference

0 references

author name string

Jayant A Talwalkar

1

1 reference

12 May 2018

Jessica J Donlinger

2

1 reference

12 May 2018

Andrea A Gossard

3

1 reference

12 May 2018

Jill C Keach

4

1 reference

12 May 2018

Roberta A Jorgensen

5

1 reference

12 May 2018

Janice C Petz

6

1 reference

12 May 2018

Keith D Lindor

7

1 reference

12 May 2018

publication date

20 October 2006

1 reference

12 May 2018

Digestive Diseases and Sciences

published in

1 reference

12 May 2018

volume

51

1 reference

12 May 2018

issue

11

1 reference

12 May 2018

page(s)

1985-1991

1 reference

12 May 2018

https://scigraph.springernature.com/pub.10.1007/s10620-006-9397-5

exact match

0 references

cites work

Measuring the functional impact of fatigue: initial validation of the fatigue impact scale.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10620-006-9397-5

Validation of a fatigue impact score in primary biliary cirrhosis: towards a standard for clinical and trial use.

21 January 2018

1 reference

12 December 2020

Defective corticotropin-releasing hormone mediated neuroendocrine and behavioral responses in cholestatic rats: implications for cholestatic liver disease-related sickness behaviors

1 reference

12 December 2020

Endocrine function in multiple sclerosis

1 reference

12 December 2020

Case report: oral antioxidant therapy for the treatment of primary biliary cirrhosis: a pilot study.

1 reference

12 December 2020

Relief from profound fatigue associated with chronic liver disease by long-term ondansetron therapy

1 reference

12 December 2020

Oral antioxidant supplementation for fatigue associated with primary biliary cirrhosis: results of a multicentre, randomized, placebo-controlled, cross-over trial

1 reference

12 December 2020

Impact of fatigue on the quality of life of patients with primary biliary cirrhosis.

1 reference

12 December 2020

Cholestatic liver diseases and health-related quality of life

1 reference

12 December 2020

The true impact of fatigue in primary biliary cirrhosis: a population study

1 reference

12 December 2020

Increased sensitivity to the locomotor-activating effects of corticotropin-releasing hormone in cholestatic rats.

1 reference

12 December 2020

Primary biliary cirrhosis: clinical features and outcome, with special reference to asymptomatic disease

1 reference

12 December 2020

Fatigue in chronic disease

1 reference

12 December 2020

Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group.

1 reference

12 December 2020

Augmented interleukin-1beta-induced depression of locomotor activity in cholestatic rats

1 reference

12 December 2020

A randomized, controlled crossover trial of ondansetron in patients with primary biliary cirrhosis and fatigue

1 reference

12 December 2020

Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease

1 reference

12 December 2020

Primary biliary cirrhosis--a revised clinical spectrum

1 reference

12 December 2020

Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome

1 reference

12 December 2020

Fatigue in primary biliary cirrhosis

1 reference

12 December 2020

The Presentation and Diagnosis of 100 Patients with Primary Biliary Cirrhosis

1 reference

12 December 2020

Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients.

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis.

1 reference

12 December 2020

The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.

1 reference

12 December 2020

The demography of primary biliary cirrhosis in Ontario, Canada

1 reference

12 December 2020

Chronic cholestasis in rats induces anhedonia and a loss of social interest

1 reference

12 December 2020

Early features of primary biliary cirrhosis: an analysis of 85 patients.

1 reference

12 December 2020

Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years

1 reference

12 December 2020

The natural history of primary biliary cirrhosis

1 reference

12 December 2020

Assessing quality of life in primary biliary cirrhosis

1 reference

12 December 2020

Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the Liver

1 reference

12 December 2020

Hypothalamic-pituitary-adrenal axis function in patients with active rheumatoid arthritis: a controlled study using insulin hypoglycemia stress test and prolactin stimulation.

1 reference

12 December 2020

Ursodeoxycholic acid in the treatment of primary biliary cirrhosis

1 reference

12 December 2020

Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis

1 reference

12 December 2020

10.1007/S10620-006-9397-5

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018